Living in redlined areas associated with lower lung function in those with asthma
Individuals with asthma who live in redlined neighborhoods have worse lung function than those in locales that excluded Black people and benefited from decades of inequitable wealth accumulation at the expense of Black communities in the United States, according to research presented at the ATS 2021 International Conference.
Alexander Schuyler, MD/PhD candidate, University of Pittsburgh School of Medicine, and Sally Wenzel, MD, director, Asthma & Environmental Lung Health Institute, University of Pittsburgh Medical Center, sought to examine the connection between residence in historically redlined communities and the impact on lung function and asthma outcomes. Redlining is a form of institutional racism and discriminatory mortgage lending practice enacted by the Home Owners’ Loan Corporation in the New Deal era that resulted in racialized economic deprivation and segregation. These historically val
That s out of more than 4.6 million fully vaccinated residents, according to state data.
Chicago s top doctor said earlier this month that the city s rate of infection post-vaccination was low, with 0.06% of fully vaccinated people contracting the virus. We ve had more than 700,000 Chicagoans that are have a completed vaccine series - two weeks post their second dose, or two weeks post their first dose if they got J&J, Chicago Department of Public Health Commissioner Dr. Allison Arwady said last week. And at this point we ve identified fewer than 500 breakthrough cases so that s, you know, 0.06% of those who had a completed series.
Operator
Good day, and thank you for standing by and welcome to the Inari Medical Inc. Q1 2021 earnings conference call.[Operator Instructions] I would now like to hand the conference over to your speaker today, Caroline Corner of investor relations. Please go ahead.
Caroline Corner
Investor Relations
Thank you, operator. Welcome to Inari s first-quarter 2021 earnings call. Joining me on today s call are Bill Hoffman, president and chief executive officer; and Mitch Hill, chief financial officer. For the Q&A session, we will also be joined by Drew Hykes, chief operating officer; and Dr.
Tom Tu, chief medical officer. This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding the markets in which Inari operates, trends and expectations for Inari s prod
How insurers race to digitize has changed the role of CIO
How insurers race to digitize has changed the role of CIO
Nona Tepper and Jessica Kim Cohen
Print
Last February, Lisa Davis started her new job as chief information officer of Blue Shield of California, entering the healthcare industry for the first time with a new set of responsibilities and a charge to transform the Oakland-based insurer s previous operating model. A month later, COVID-19 hit. Who knew that when I took the job on February 24, 2020, that we would be entering into this global pandemic? Davis said.
Davis considers herself fortunate. Blue Shield of California had already laid out its digital transformation strategy. Insurers tight focus on crisis planning helped the industry adapt well during COVID. But even the most prepared underwent transformation.
SHARE
The
Global Consortium Study of Neurologic Dysfunction in Covid-19 says hospital patients with clinically diagnosed neurological signs are six times more likely to die than those without.
Read More Very early on in the pandemic it became apparent that a good number of people who were sick enough to be hospitalised also developed neurological problems, said Dr Sherry Chou, lead author and associate professor of critical care medicine, neurology and neurosurgery at the University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Centre (UPMC). A year later we are still fighting an unknown invisible enemy and, like in any battle, we need intel – we have to learn as much as we can about neurological impacts of Covid-19 in patients who are actively sick and in survivors.